[
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript",
    "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2024 Earnings Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsSusie Lisa - Senior Vice...",
    "url": "https://finnhub.io/api/news?id=1660a10c42a72fae589dd62259a4db56441211bd0f0aaf4540e5b650ae700204",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739219170,
      "headline": "Vertex Pharmaceuticals Incorporated (VRTX) Q4 2024 Earnings Call Transcript",
      "id": 132653059,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q4 2024 Earnings Conference Call February 10, 2025 4:30 PM ETCompany ParticipantsSusie Lisa - Senior Vice...",
      "url": "https://finnhub.io/api/news?id=1660a10c42a72fae589dd62259a4db56441211bd0f0aaf4540e5b650ae700204"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Incorporated 2024 Q4 - Results - Earnings Call Presentation",
    "summary": "The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2024 Q4 earnings call.",
    "url": "https://finnhub.io/api/news?id=ba4094da11af65f9b5db2337521d0c710b732d86c9c7ef135d541c514f1fc24b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739212954,
      "headline": "Vertex Pharmaceuticals Incorporated 2024 Q4 - Results - Earnings Call Presentation",
      "id": 132646422,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The following slide deck was published by Vertex Pharmaceuticals Incorporated in conjunction with their 2024 Q4 earnings call.",
      "url": "https://finnhub.io/api/news?id=ba4094da11af65f9b5db2337521d0c710b732d86c9c7ef135d541c514f1fc24b"
    }
  },
  {
    "ts": null,
    "headline": "Vertex Pharmaceuticals Posts Higher 4Q Revenue",
    "summary": "Vertex Pharmaceuticals Posts Higher 4Q Revenue",
    "url": "https://finnhub.io/api/news?id=4d2e21d70084f44d67851a8d927b483f9678fce501f9ddc0b9539712db3b0776",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739206560,
      "headline": "Vertex Pharmaceuticals Posts Higher 4Q Revenue",
      "id": 132661897,
      "image": "",
      "related": "VRTX",
      "source": "MarketWatch",
      "summary": "Vertex Pharmaceuticals Posts Higher 4Q Revenue",
      "url": "https://finnhub.io/api/news?id=4d2e21d70084f44d67851a8d927b483f9678fce501f9ddc0b9539712db3b0776"
    }
  },
  {
    "ts": null,
    "headline": "Tweedy, Browne Fund Q2 2024 Commentary",
    "summary": "The bull market in global equities continued to modestly grind ahead in the 2nd quarter. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=18ab4999a3d94c838a04ef9829ae164a8f996e52efd547c6a976ee06f69b8f41",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739186400,
      "headline": "Tweedy, Browne Fund Q2 2024 Commentary",
      "id": 132634530,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2191113686/image_2191113686.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "The bull market in global equities continued to modestly grind ahead in the 2nd quarter. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=18ab4999a3d94c838a04ef9829ae164a8f996e52efd547c6a976ee06f69b8f41"
    }
  },
  {
    "ts": null,
    "headline": "Tweedy, Browne Fund Q4 2024 Commentary",
    "summary": "Setting aside a rather brief hiccup mid-quarter, the bull market in global equities continued in force during Q4 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=e02945fdabaed045becd514285a918f53131f289764f0daac05ac0a6e35faaf7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1739149200,
      "headline": "Tweedy, Browne Fund Q4 2024 Commentary",
      "id": 132630159,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358927461/image_1358927461.jpg?io=getty-c-w1536",
      "related": "VRTX",
      "source": "SeekingAlpha",
      "summary": "Setting aside a rather brief hiccup mid-quarter, the bull market in global equities continued in force during Q4 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=e02945fdabaed045becd514285a918f53131f289764f0daac05ac0a6e35faaf7"
    }
  }
]